Current Drug Targets

Editor-in-Chief

Francis J. Castellino
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 3 Issue: 4, August

Preface

Volume:3   Issue: 4
Pp: i-i
Maria Paola Costi
DOI: 10.2174/1389450023347632
Published on: 01 March, 2012

Hepatitis C Virus Proteins as Targets for Drug Development: The Role of Bioinformatics and Modelling

Volume:3   Issue: 4
Pp: 281-296
A. Lahm, A. Yagnik, A. Tramontano and U. Koch
DOI: 10.2174/1389450023347650
Published on: 01 March, 2012

The Means to an End of Tumor Cell Resistance to Chemotherapeutic Drugs Targeting Thymidylate Synthase: Shoot the Messenger

Volume:3   Issue: 4
Pp: 297-309
Randal W. Berg, Peter J. Ferguson, Janice M. DeMoor, Mark D. Vincent and James Koropatnick
DOI: 10.2174/1389450023347605
Published on: 01 March, 2012

Multidrug Resistance Phenotype Mediated by the P-Glycoprotein-Like Transporter in Leishmania: A Search for Reversal Agents

Volume:3   Issue: 4
Pp: 311-333
J. M. Perez-Victoria, A. Di Pietro, D. Barron, A. G. Ravelo, S. Castanys and F. Gamarro
DOI: 10.2174/1389450023347588
Published on: 01 March, 2012

Streptogramin Antibiotics: Mode of Action and Resistance

Volume:3   Issue: 4
Pp: 335-344
Nicole J. Johnston, Tariq A. Mukhtar and Gerard D. Wright
DOI: 10.2174/1389450023347678
Published on: 01 March, 2012

Mutation and Evolution of Antibiotic Resistance: Antibiotics as Promoters of Antibiotic Resistance?

Volume:3   Issue: 4
Pp: 345-349
Jesus Blazquez, Antonio Oliver and Jose-Maria Gomez-Gomez
DOI: 10.2174/1389450023347579
Published on: 01 March, 2012